Company Data

Sonnet BioTherapeutics Holdings Inc.

Ticker
SONN
Current Price
$1.125 0.45%
Market Cap
$3.6M
Price Target
Refer to Report
Volume
14.6K
52wk Range
$1.08 - $16
Advanced Market Data

Overview

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm’s pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy